ENDRA announces a private placement to fund its entry into digital assets, centering on a substantial HYPE token investment as part of active treasury management.
ENDRA Life Sciences, a Nasdaq-listed medical technology firm, announced via press release that it closed a private placement to support its expansion into digital assets. The company has immediately deployed capital into HYPE tokens, positioning the asset as a core component of its active treasury management strategy. This follows its October 21 purchase of 78,863.1 HYPE tokens valued at approximately $3 million. The financing, totaling $4.9 million, was executed through a PIPE transaction on October 23.